News | Breast Imaging | May 19, 2016

American Society of Breast Surgeons Awards Cianna Medical for Savi Scout System

Breast localization and surgical guidance system given peer-selected award for greatest scientific impact on breast cancer care

Cianna Medical, Savi Scout breast localization and surgical guidance system, American Society of Breast Surgeons, Scientific Impact Award

May 19, 2016 — Cianna Medical Inc. recently announced receipt of the 2016 Scientific Impact Award at the Society of Breast Surgeons (ASBrS) Annual Meeting for data presented validating the clinical utility of Savi Scout breast localization and surgical guidance system. The Scientific Impact Award is given to the clinical research presentation that is considered to have the greatest scientific impact on breast cancer care, as judged by surgeon attendees.

Scout, a U.S. Food and Drug Administration (FDA)-cleared breast lesion localization tool that uses micro-impulse radar to localize and direct the removal of non-palpable breast lesions, became available in late 2015. The technology has been rapidly adopted by physicians and is now in use at more than 50 medical centers across the United States.

Based on a separate research report, U.S.-based hospital executives have changed how they think about cost containment and are focusing their efforts on maximizing performance against quality metrics and driving operational efficiency.  It has also been reported that nearly 40 percent of all healthcare providers are willing to shift toward technologically advanced options for breast lesion localization that do not require invasive wires or radiation and have been shown to improve patient care.

The data presented during ASBrS showed that Scout achieved 100 percent surgical success, high clinical reproducibility, and favorable physician and patient satisfaction. Additionally, 97 percent of patients in the study would recommend SCOUT to other women.

The presentation on Scout was made by Nashville-based breast surgeon Pat Whitworth, M.D.  He accepted the award on behalf of Charles Cox, M.D., the Tampa, Fla.-based lead study investigator, himself and the other clinical study investigators. Whitworth is a breast surgical oncologist and director of the Nashville Breast Center. Cox is professor of surgery and McCann Foundation Endowed Professor of Breast Surgery, University of South Florida College of Medicine, director of The University of South Florida Breast Health Program and medical director of Morsani Ambulatory Surgery Center.

The Scout system features micro-impulse radar to detect a reflector that is placed at the tumor site up to seven days before a lumpectomy or surgical biopsy. During the procedure, the surgeon scans the breast using the Scout handpiece, which emits infrared light and a micro-impulse signal to detect the location of the reflector. Real-time audible and visual indicators assist the surgeon in accurately locating the reflector, along with the target tissue. This higher level of localization precision allows the surgeon to plan a surgical approach that may result in a better cosmetic outcome.

For more information: www.ciannamedical.com

Related Content

Stronger Distribution Networks to Bolster Radiotherapy Patient Positioning Accessories
News | Patient Positioning Radiation Therapy | July 19, 2019
A recent study projects global market revenues for radiotherapy patient positioning accessories will exceed revenues of...
IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
CMS Proposes New Alternative Payment Model for Radiation Oncology
News | Radiation Oncology | July 17, 2019
The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM)...
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
RaySearch Releases Version 3A of RayCare Oncology Information System
Technology | Oncology Information Management Systems (OIMS) | July 15, 2019
RaySearch has released RayCare 3A, a new version of the next-generation oncology information system (OIS). RayCare is...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
IBA Launches Monte Carlo Patient QA for Varian Halcyon at AAPM 2019
Technology | Quality Assurance (QA) | July 10, 2019
IBA announced the launch of the latest functionality of the SciMoCa Monte Carlo Patient QA solution at the 61st annual...